Targeting thymidine phosphorylase as a potential therapy for bone loss associated with periprosthetic osteolysis-Reference-Cited by-同舟云学术

Targeting thymidine phosphorylase as a potential therapy for bone loss associated with periprosthetic osteolysis

Published:2021-06-08 Issue:3 Volume:6 Page:
ISSN:2380-6761
Container-title:Bioengineering & Translational Medicine
language:en
Short-container-title:Bioeng Transl Med

Author:

Matsumae Gen¹,Shimizu Tomohiro¹,Tian Yuan¹,Takahashi Daisuke¹,Ebata Taku¹,Alhasan Hend¹,Yokota Shunichi¹,Kadoya Ken¹,Terkawi Mohamad Alaa¹²^ORCID,Iwasaki Norimasa¹²

Affiliation:

1. Department of Orthopedic Surgery, Faculty of Medicine and Graduate School of Medicine Hokkaido University Sapporo Japan

2. Global Institution for Collaborative Research and Education (GI‐CoRE), Frontier Research Center for Advanced Material and Life Science Bldg No 2. Hokkaido University Sapporo Japan

Funder

Akiyama Life Science Foundation

Japan Agency for Medical Research and Development

Japan Society for the Promotion of Science

Kobayashi Foundation for Cancer Research

Publisher

Wiley

Subject

Pharmaceutical Science,Biomedical Engineering,Biotechnology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/btm2.10232

Reference47 articles.